- 米国企業
- LEAP THERAPEUTICS, INC.
LEAP THERAPEUTICS, INC.LPTX
時価総額
$6723.7万
PER
| 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
| License revenue | - | - | - | 2 | 2 | - |
| Research and development | 23 | 22 | 24 | 20 | 32 | 45 |
| General and administrative | 10 | 9 | 9 | 10 | 11 | 12 |
| Total operating expenses | 32 | 31 | 33 | 30 | 43 | 57 |
| Loss from operations | -32 | -31 | -33 | -29 | -41 | -57 |
| Interest income | 0 | 0 | 0 | 0 | 0 | 1 |
| Interest expense | - | 0 | 0 | 0 | 0 | 0 |
| Research And Development Incentive Income | 2 | 1 | 0 | 0 | 1 | 2 |
| Foreign currency loss | 1 | -1 | 0 | 1 | -0 | -1 |
| Loss before income taxes | -30 | -23 | -33 | -28 | -41 | -54 |
| Benefit from (provision for) income taxes | -0 | 0 | -0 | -0 | -0 | 0 |
| Net loss attributable to common stockholders | -30 | -23 | -33 | -38 | -41 | -55 |
| Basic | -3.27 | -1.64 | -1.47 | -0.63 | -0.47 | -0.48 |
| Diluted | -3.31 | -2.11 | -1.47 | -0.63 | -0.47 | -0.48 |